UBS Group AG

Position in ADXN — Addex Therapeutics Ltd.

CIK 1610520 ZURICH, V8

Position in ADXN

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$267

-$937 QoQ

Shares Held

-69.9% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 2 holders

Holding Since

Sep 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,672,124 across 561 Biotechnology names. ADXN ranks #528 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	5,450,825	$1,020,369,609
2	ROIV	Roivant Sciences Ltd.	17,466,641	$618,144,423
3	PTGX	Protagonist Therapeutics, Inc	3,399,221	$416,676,508
4	VRTX	Vertex Pharmaceuticals Inc / Ma	712,259	$353,800,411
5	MRNA	Moderna, Inc.	4,463,211	$312,558,664
6	INSM	INSMED Inc	2,584,446	$275,553,630
7	ABVX	Abivax S.A.	1,844,918	$245,853,771
8	MDGL	Madrigal Pharmaceuticals, Inc.	401,708	$215,697,109

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$267	47	-69.9%	Shares	Defined	2026-08-13
2025-12-31	$1,204	156	+15500.0%	Shares	Defined	2026-01-29
2025-09-30	$9	1	-98.6%	Shares	Defined	2025-11-13
2023-09-30	$28	74	-99.5%	Shares	Sole	2023-11-09
2022-12-31	$9,151	14,526	+106.5%	Shares	Sole	2023-02-08
2022-09-30	$5,626	7,033	-11.6%	Shares	Sole	2022-11-10
2022-06-30	$9,147	7,954	+183.5%	Shares	Sole	2022-08-10
2022-03-31	$14,254	2,806	-83.8%	Shares	Sole	2022-05-16
2021-12-31	$108,817	17,300	+33.1%	Shares	Sole	2022-02-14
2021-09-30	$117,130	13,000	+2.2%	Shares	Sole	2021-11-15
2021-06-30	$121,542	12,715	+404.6%	Shares	Sole	2021-08-13
2021-03-31	$26,460	2,520	+2420.0%	Shares	Sole	2021-05-12
2020-12-31	$1,340	100	-91.3%	Shares	Sole	2021-02-11
2020-09-30	$14,036	1,144	—	Shares	Sole	2020-11-12
No filing history on record for this holder in this stock.